Possible carcinogen found in popular heartburn meds
Regulators in the U.S. and EU are taking a closer look at medication containing ranitidine after the presence of a probable carcinogen was found in several samples. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 16, 2019 Category: Pharmaceuticals Source Type: news
AstraZeneca diabetes drug gets fast track designation for heart indication
The prospects for an AstraZeneca diabetes drug receiving a major new indication are looking even brighter. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 16, 2019 Category: Pharmaceuticals Source Type: news
Considering going direct from manufacturers to providers?
Cutting out the middleman will mean redesigning the supply chain and increasing costs (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 16, 2019 Category: Pharmaceuticals Source Type: news
Lundbeck buys Alder, eyeing migraine drug
Denmark ’s Lundbeck has agreed to buy Alder BioPharmaceuticals in a deal valued at almost $2 billion, hoping to profit from a potential blockbuster migraine drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 16, 2019 Category: Pharmaceuticals Source Type: news
Purdue Pharma files for bankruptcy as part of opioid settlement
Purdue Pharma filed for Chapter 11 bankruptcy in New York as part of its framework for settling litigation with states and local governments in a massive opioid lawsuit. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 16, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 9/13/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 13, 2019 Category: Pharmaceuticals Source Type: news
Vertex to sell cystic fibrosis drugs in Scotland
Amid Vertex ’s continuing drug pricing battle with British regulators, the drugmaker has signed a deal to make two of its cystic fibrosis drugs available in Scotland. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 13, 2019 Category: Pharmaceuticals Source Type: news
CAR-T may treat heart disease, says study
A first-of-its-kind study by researchers at Penn Medicine found that CAR-T cell therapy may be a viable treatment option for heart disease. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 12, 2019 Category: Pharmaceuticals Source Type: news
Bayer reduces management board amid ongoing company shake-up
Bayer ’s quest to reduce its workforce has traveled all the way up into the company’s highest ranks. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 12, 2019 Category: Pharmaceuticals Source Type: news
Sanofi forks over $260M to end diabetes partnership
Sanofi will pay Lexicon Pharmaceuticals $260 million to terminate a partnership related to the development of a diabetes drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 12, 2019 Category: Pharmaceuticals Source Type: news
Data analytics moves beyond Dilbert
Why pharma manufacturers shouldn ’t get stuck in a comic (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 11, 2019 Category: Pharmaceuticals Source Type: news
Mallinckrodt offloads BioVectra for $250 million
The company has agreed to sell its contract manufacturing unit to alleviate some of its debt woes as it faces a myriad of opioid lawsuits (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 10, 2019 Category: Pharmaceuticals Source Type: news
FDA OKs Xeris Pharma low blood sugar pen
The company announced positive results from two of its Phase 3 clinical studies on the investigational ready-to-use, room-temperature stable liquid glucagon rescue pen at the American Diabetes Association ’s 78th Scientific Sessions (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 10, 2019 Category: Pharmaceuticals Source Type: news
Novartis CEO pledges to proactively speed up disclosing data integrity issues
The company head promised to voluntarily notify the FDA within five business days of receipt of any credible allegation related to data integrity impacting any pending application (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 9, 2019 Category: Pharmaceuticals Source Type: news
Experimental Lilly med shrank nearly 70% of tumors in lung cancer trial
The drug LOXO-292 was acquired by the drugmaker in the beginning of the year when it took
over Loxo Oncology for $8 billion (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 9, 2019 Category: Pharmaceuticals Source Type: news
